New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 5, 2014
07:57 EDTCVDCovance weakness overdone, says Wells Fargo
After Covance reported stronger than expected Q1 results on Friday but its stock declined, Wells Fargo thinks the move was likely caused by the simultaneous deceleration of clinical growth and weaker ED margins. However, the firm thinks the company can meet analysts' 2015 estimates and it keeps an Outperform rating on the stock.
News For CVD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 23, 2015
05:41 EDTCVDLabCorp upgraded to Overweight from Neutral at Piper Jaffray
Subscribe for More Information
February 19, 2015
09:22 EDTCVDLabCorp completes acquisition of Covance
LabCorp (LH) announced the completion of its acquisition of Covance (CVD), following its entry into a definitive purchase agreement on November 2, 2014. At closing, the purchase consideration was valued at $107.19 per Covance share, consisting of $75.76 in cash and 0.2686 LabCorp shares for each Covance share, or an equity value of approximately $6.2B and an enterprise value of approximately $5.7B. The closing of the transaction follows the receipt of all necessary regulatory requirements and approval of the transaction by Covance shareholders on February 18. With the closing of the transaction, Covance common stock will cease trading and will no longer be listed on the NYSE.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use